Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) Net Margin (2016 - 2025)

Prestige Consumer Healthcare has reported Net Margin over the past 16 years, most recently at 16.47% for Q4 2025.

  • For Q4 2025, Net Margin fell 455.0% year-over-year to 16.47%; the TTM value through Dec 2025 reached 16.9%, down 223.0%, while the annual FY2025 figure was 18.86%, 26.0% up from the prior year.
  • Net Margin for Q4 2025 was 16.47% at Prestige Consumer Healthcare, up from 15.4% in the prior quarter.
  • Over five years, Net Margin peaked at 21.46% in Q2 2021 and troughed at 84.15% in Q1 2023.
  • A 5-year average of 13.18% and a median of 18.54% in 2024 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: tumbled -10366bps in 2023 and later soared 10200bps in 2024.
  • Year by year, Net Margin stood at 18.3% in 2021, then grew by 3bps to 18.86% in 2022, then decreased by 0bps to 18.76% in 2023, then increased by 12bps to 21.02% in 2024, then decreased by -22bps to 16.47% in 2025.
  • Business Quant data shows Net Margin for PBH at 16.47% in Q4 2025, 15.4% in Q3 2025, and 19.02% in Q2 2025.